Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEssentra Regulatory News (ESNT)

Share Price Information for Essentra (ESNT)

Share Price is delayed by 15 minutes
Get Live Data
80.40    -0.60 (-0.74%)
Bid:
80.10
Ask:
80.70
Spread: 0.60 (0.749%)
Market Cap: £225.28m
ESNT Live PriceLast checked at - London Stock Exchange

Intraday Essentra Share Chart

Directorate Change

7 Nov 2024 15:27

RNS Number : 4192L
Essentra plc
07 November 2024
 

 

 

 

 

ESSENTRA PLC

 

BOARD CHANGES

 

Further to the announcement on 10 September 2024, Essentra plc, a leading global manufacturer and provider of essential components and solutions, confirms that Rowan Baker was appointed to the Board as CFO on 5 November 2024. Jack Clarke will step down from the Board on 1 January 2025.

 

Further information please contact:

Essentra plc

Scott Fawcett, Chief Executive

Emma Reid, Company Secretary

 

Tel: +44 (0)1908 359100

FTI Consulting

Richard Mountain

Ariadna Peretz

FTI_essentra@fticonsulting.com

Tel: +44 (0)20 3727 1340

 

LEI: 5493007MOZNA03BVNE96

 

Notes to Editors

About Essentra plc

Essentra plc is a FTSE 250 company and a leading global manufacturer and provider of essential components and solutions, focusing on the manufacture and distribution of plastic injection moulded, vinyl dip moulded and metal items.

Headquartered in the United Kingdom, Essentra's global network extends to 28 countries worldwide and includes c.3,000 employees, 14 manufacturing facilities, 24 distribution centres and 33 sales & service centres serving c.69,000 customers with a rapid supply of low cost but essential products for a variety of applications in industries such as equipment manufacturing, automotive, fabrication, electronics, medical and renewable energy.

For further information, please visit www.essentraplc.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOABRBATMTTMBAI
Date   Source Headline
18th Apr 20237:00 amRNSTransaction in Own Shares
17th Apr 20233:32 pmRNSNotice of AGM
17th Apr 20237:00 amRNSTransaction in Own Shares
14th Apr 20237:00 amRNSTransaction in Own Shares
13th Apr 20237:00 amRNSTransaction in Own Shares
12th Apr 20237:00 amRNSTransaction in Own Shares
11th Apr 20237:00 amRNSTransaction in Own Shares
6th Apr 20238:19 amRNSDirector/PDMR Shareholding
6th Apr 20237:00 amRNSTransaction in Own Shares
5th Apr 20237:00 amRNSTransaction in Own Shares
4th Apr 20238:49 amRNSDirector/PDMR Shareholding
4th Apr 20237:00 amRNSTransaction in Own Shares
3rd Apr 20237:02 amRNSDirector/PDMR Shareholding
3rd Apr 20237:00 amRNSTransaction in Own Shares
30th Mar 20237:00 amRNSTransaction in Own Shares
29th Mar 20237:05 amRNSStatement re Launch of Share Buyback Programme
29th Mar 20237:00 amRNSResults for the Full Year Ended 31 December 2022
21st Mar 20234:03 pmRNSStatement re 2022 Full Year Results Revised Date
2nd Mar 202310:20 amRNSNotice of Full Year 2022 Results
1st Mar 20239:19 amRNSTotal Voting Rights
21st Feb 20238:00 amRNSHolding(s) in Company
2nd Feb 20237:00 amRNSSpecial Dividend and Share Buyback Programme
1st Feb 20238:00 amRNSTotal Voting Rights
18th Jan 202312:06 pmRNSDirector Declaration
6th Jan 20237:00 amRNSFY22 Pre-Close Trading Update
3rd Jan 20237:10 amRNSTotal Voting Rights
3rd Jan 20237:00 amRNSDirectorate Change
20th Dec 202210:47 amRNSHolding(s) in Company
16th Dec 20227:00 amRNSDirectorate Change
16th Dec 20227:00 amRNSHolding(s) in Company
14th Dec 20227:00 amRNSHolding(s) in Company
7th Dec 202212:00 pmRNSHolding(s) in Company
5th Dec 202210:31 amRNSCompletion of the sale of Filters business
5th Dec 20229:10 amRNSTotal Voting Rights
1st Dec 20228:00 amRNSHolding(s) in Company
1st Dec 20227:00 amRNSAcquisition of the Wixroyd Group
28th Nov 20227:00 amRNSHolding(s) in Company
17th Nov 20222:40 pmRNSHolding(s) in Company
15th Nov 20227:00 amRNSCapital Markets Event
10th Nov 202210:43 amRNSHolding(s) in Company
9th Nov 202212:49 pmRNSResult of General Meeting
7th Nov 20227:00 amRNSHolding(s) in Company
2nd Nov 20227:00 amRNSTotal Voting Rights
28th Oct 20222:36 pmRNSCapital Markets Event - date rescheduled
21st Oct 20222:48 pmRNSCirc re. Publication of Class 1 and Notice of GM
21st Oct 20227:00 amRNSQ3 2022 Trading Update
18th Oct 20224:04 pmRNSHolding(s) in Company
17th Oct 20228:32 amRNSHolding(s) in Company
10th Oct 202212:11 pmRNSDirector/PDMR Shareholding
6th Oct 202212:33 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.